- Home
- ICMB vs PEPG Comparison
ICMB vs PEPG Comparison
Compare ICMB & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- PEPG
- Stock Information
- Founded
- ICMB 2012
- PEPG 2018
- Country
- ICMB United States
- PEPG United States
- Employees
- ICMB N/A
- PEPG N/A
- Industry
- ICMB Finance: Consumer Services
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- ICMB Finance
- PEPG Health Care
- Exchange
- ICMB Nasdaq
- PEPG Nasdaq
- Market Cap
- ICMB 40.6M
- PEPG 45.5M
- IPO Year
- ICMB N/A
- PEPG 2022
- Fundamental
- Price
- ICMB $2.85
- PEPG $1.45
- Analyst Decision
- ICMB
- PEPG Buy
- Analyst Count
- ICMB 0
- PEPG 3
- Target Price
- ICMB N/A
- PEPG $7.67
- AVG Volume (30 Days)
- ICMB 20.6K
- PEPG 342.9K
- Earning Date
- ICMB 09-24-2025
- PEPG 08-07-2025
- Dividend Yield
- ICMB 16.84%
- PEPG N/A
- EPS Growth
- ICMB N/A
- PEPG N/A
- EPS
- ICMB 0.82
- PEPG N/A
- Revenue
- ICMB $20,996,189.00
- PEPG N/A
- Revenue This Year
- ICMB N/A
- PEPG N/A
- Revenue Next Year
- ICMB N/A
- PEPG N/A
- P/E Ratio
- ICMB $3.46
- PEPG N/A
- Revenue Growth
- ICMB N/A
- PEPG N/A
- 52 Week Low
- ICMB $2.46
- PEPG $0.88
- 52 Week High
- ICMB $3.47
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- ICMB 52.30
- PEPG 58.91
- Support Level
- ICMB $2.75
- PEPG $1.37
- Resistance Level
- ICMB $2.90
- PEPG $1.47
- Average True Range (ATR)
- ICMB 0.08
- PEPG 0.08
- MACD
- ICMB 0.00
- PEPG 0.03
- Stochastic Oscillator
- ICMB 66.67
- PEPG 94.12
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.